Kinentia Biosciences

Kinentia Biosciences is a privately held contract research and manufacturing organization headquartered in Rensselaer, New York. The company employs five individuals and generates approximately $2.5 million in annual revenue. Kinentia Biosciences provides contract research and manufacturing services to support drug discovery and development. Their offerings encompass the entire spectrum, from preclinical and clinical research to manufacturing. They specialize in chemistry services, including medicinal chemistry, process research and development, and CMC dossier preparation and review. Additionally, Kinentia offers consulting services leveraging their expertise in drug discovery, development, chemo-informatics, and platform technology. Kinentia distinguishes itself through its comprehensive approach, combining contract research and manufacturing capabilities with consulting expertise and a platform chemo-informatics technology. Their subsidiary, KCS-Online, offers a catalog of chemical intermediates, building blocks, and natural products, many of which are novel and possess drug-like properties. Interested parties can contact Kinentia Biosciences via email at [email protected] or visit their website at www.kinentia.com.